Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03505983 · ClinicalTrials.gov registry record · NA
Criteria for Advanced Prosthetic Foot Prescription
A NA study of Prosthesis User and Amputation; Traumatic, Limb, Lower, sponsored by VA New York Harbor Healthcare System.
- Active
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT03505983: Active NA study of Prosthesis User and Amputation; Traumatic, Limb, Lower, sponsored by VA New York Harbor Healthcare System.
NCT03505983 is a NA study of Prosthesis User and Amputation; Traumatic, Limb, Lower that is active but no longer recruiting, run by VA New York Harbor Healthcare System. The registered enrollment target is 91 participants, above the 50-participant average among 12 other Prosthesis User trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03505983, a NA study of Prosthesis User and Amputation; Traumatic, Limb, Lower, is active but no longer recruiting, sponsored by VA New York Harbor Healthcare System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop criteria for prosthetic foot prescription for Veterans and Service Members with transtibial limb loss. The objectives are to: 1) Determine the appropriate functional outcome tests and measures to support the prescription of a type of Energy Storing and Returning (ESR) non-articulating, articulating or active plantarflexion prosthetic ankle-foot for a Veteran or Service Member with transtibial limb loss. 2) Correlate patient goals and subjective measures with objective data to determine the appropriate prosthetic ankle-foot category that will facilitate the greatest overall function to the user. 3) Develop criteria for the appropriate prescription of non-articulating ESR, articulating ESR, and active plantar flexion ESR ankle-foot units.
Primary Outcome
The 6-minute walk test measures the distance an individual can walk in 6 minutes without help or encouragement.
Conditions Studied
Interventions
- DEVICE ESR Prosthetic Foot First
- DEVICE Articulating ESR Prosthetic Foot First
- DEVICE Powered Prosthetic Foot First
Study Locations (1)
New York
- VA New York Harbor Healthcare System - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What the registry record for NCT03505983 still lists
NCT03505983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, above the 50-participant average among 12 other Prosthesis User trials with a reported enrollment target (82% higher).
The record links to 2 conditions, with Prosthesis User appearing as the primary indexed condition, and to 3 interventions - of which ESR Prosthetic Foot First is the first listed.
NCT03505983 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03505983 about?
NCT03505983 is a clinical study titled "Criteria for Advanced Prosthetic Foot Prescription". The purpose of this study is to develop criteria for prosthetic foot prescription for Veterans and Service Members with transtibial limb loss. The objectives are to: 1) Determine the appropriate functional outcome tests and measures to support the prescription of a type of Energy Storing and Returni...
What is the current status of trial NCT03505983?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2018-03-07. Estimated completion is 2026-09-01.
What conditions does trial NCT03505983 study?
This clinical trial studies the following conditions: Prosthesis User, Amputation; Traumatic, Limb, Lower.
What interventions are being tested in trial NCT03505983?
The interventions under investigation include: ESR Prosthetic Foot First (DEVICE), Articulating ESR Prosthetic Foot First (DEVICE), Powered Prosthetic Foot First (DEVICE).
Who is sponsoring clinical trial NCT03505983?
This trial is sponsored by VA New York Harbor Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03505983 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prosthesis User
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03505983's enrollment target sits among peer trials
91 4th of 12 higher than 9 of 12 other Prosthesis User trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prosthesis User trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neural Enabled Prosthesis for Upper Limb Amputees
RECRUITING · NA
-
Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees
RECRUITING · NA
-
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
RECRUITING · NA
-
Effects of Microprocessor-controlled Prosthetic Knees on Fall-related Health Outcomes in Limited Community Ambulators
RECRUITING · NA
-
Caesar Foot Take-Home Validation Testing
RECRUITING · NA
-
Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI